Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy

被引:0
|
作者
M Schaapveld
E G E de Vries
R Otter
J de Vries
W V Dolsma
P H B Willemse
机构
[1] Comprehensive Cancer Center North-Netherlands,Department of Medical Oncology
[2] University Medical Center Groningen,Department of Surgical Oncology
[3] University Medical Center Groningen,Department of Radiotherapy
[4] University Medical Center Groningen,Department of Medical Oncology
[5] University Medical Center Groningen,undefined
来源
British Journal of Cancer | 2005年 / 93卷
关键词
breast cancer; regional variation; breast-conserving surgery; guideline adherence; sentinel node biopsy;
D O I
暂无
中图分类号
学科分类号
摘要
This population-based study aimed to analyse variations in surgical treatment and guideline compliance with respect to the application of radiotherapy and axillary lymph node dissection (ALND), for early breast cancer, before and after the sentinel node biopsy (SNB) introduction. The study included 13 532 consecutive surgically treated stage I–IIIA breast cancer patients diagnosed in 1989–2002. Hospitals showed large variation in breast-conserving surgery (BCS) rates, ranging between 27 and 72% for T1 and 14 and 42% for T2 tumours. In multivariate analysis marked inter-hospital and time-dependent variation in the BCS rate remained after correction for case-mix. The guideline adherence was markedly lower for elderly patients. In 25.2% of the patients aged ⩾75 years either ALND or radiotherapy were omitted. The proportion of patients with no ALND after an SNB increased from 1.8% in 1999 to 37.8% in 2002. However, in 2002 also 12.2% of the patients with a positive SNB did not have an ALND. Guideline compliance for BCS, with respect to radiotherapy and ALND, fell since the SNB introduction, from 96.1% before 2000 to 91.4% in 2002 (P<0.001). Noncompliance may however reflect patient-tailored medicine, as for elderly patients with small, radically resected primary tumours. The considerable variation in BCS-rates is more consistent with variations in surgeon preferences than patient's choice.
引用
收藏
页码:520 / 528
页数:8
相关论文
共 50 条
  • [31] Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 75 - 75
  • [32] Sentinel Node Biopsy Vs Axillary Node Clearance in Early Breast Cancer
    Karki, S.
    Hassen, Y.
    Babu, E.
    Chakravorty, A.
    BRITISH JOURNAL OF SURGERY, 2021, 108 : 71 - 71
  • [33] Sentinel lymph node biopsy in a resource- limited setting: a retrospective comparison of sentinel lymph node biopsy before and after the introduction of Sentimag at an academic breast unit
    Yousef, M.
    Roodt, L.
    Masu, A.
    Nel, D.
    Malherbe, F.
    SOUTH AFRICAN JOURNAL OF SURGERY, 2023, 61 (02) : 91 - 95
  • [34] An evaluation of sentinel lymph node biopsy guideline adherence in melanoma patients
    Van Doren, Amelia Stapleton
    Shah, Hemali
    Webber, Alexis
    Klein, Paytra
    Chen, Ruthia
    Shah, Dia
    Ata, Ashar
    Davis, Lindy
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S217 - S218
  • [35] Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection
    Veronesi, U
    Galimberti, V
    Mariani, L
    Gatti, G
    Paganelli, G
    Viale, G
    Zurrida, S
    Veronesi, P
    Intra, M
    Gennari, R
    Vento, AR
    Luini, A
    Tullii, M
    Bassani, G
    Rotmensz, N
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (02) : 231 - 237
  • [36] Risk of axillary recurrence after sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer
    Tardieu, A.
    Mesnard, C.
    Margueritte, F.
    Mollard, J.
    Lacorre, A.
    Aubard, Y.
    Deluche, E.
    Gauthier, T.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2018, 46 (06): : 509 - 513
  • [37] Assessment of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy in breast cancer: before or after?
    Coutant, C.
    Jankowski, C.
    Portha, H.
    Barranger, E.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2016, 44 (06): : 345 - 349
  • [38] Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy
    Intra, M
    Trifirò, G
    Viale, G
    Rotmensz, N
    Gentilini, OD
    Soteldo, J
    Galimberti, V
    Veronesi, P
    Luini, A
    Paganelli, G
    Veronesi, U
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (11) : 895 - 899
  • [39] Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 78 - 78
  • [40] Second Biopsy of Axillary Sentinel Lymph Node for Reappearing Breast Cancer After Previous Sentinel Lymph Node Biopsy
    Mattia Intra
    Giuseppe Trifirò
    Giuseppe Viale
    Nicole Rotmensz
    Oreste D. Gentilini
    Javier Soteldo
    Viviana Galimberti
    Paolo Veronesi
    Alberto Luini
    Giovanni Paganelli
    Umberto Veronesi
    Annals of Surgical Oncology, 2005, 12 : 895 - 899